Chair: Penny Blomfield
‘Pure’ adenocarcinoma-in-situ of cervix vs. adenocarcinoma-in-situ mixed with high grade cervical neoplasia: does the distinction matter? (3586)
4:00 PM
Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma-in-situ. (3565)
4:12 PM
The reliability of colposcopy and cervical cytology in observational management of CIN 2 in women under 25. (3513)
4:24 PM
HPV Tests Prior to High Grade Cervical Histology (3568)
4:36 PM
Rates and predictors of residual disease on repeat conisation of the cervix; a state-wide Australian perspective. (3589)
4:48 PM